Respiratory syncytial virus infections in the pediatric intensive care unit: Clinical characteristics and risk factors for adverse outcomes
- 1 October 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 2 (4) , 318-323
- https://doi.org/10.1097/00130478-200110000-00006
Abstract
To describe the clinical characteristics of infants admitted to a pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV) infection, including the prevalence of indications for RSV passive antibody prophylaxis (as currently recommended by the American Academy of Pediatrics), and to identify risk factors that predict adverse outcomes among this population. Retrospective medical record review. Tertiary care PICU. Children 75th percentile) of mechanical ventilation, PICU stay, and hospital stay. Prolonged mechanical ventilation was associated with congenital heart disease (p = 0.014), chronic lung disease (p = 0.007), and noncardiac congenital malformations (p = 0.022). Only congenital heart disease was associated with prolonged PICU stay (p = 0.004) or prolonged hospital stay (p = 0.006). All of the infants with airway abnormalities had prolonged ventilator days, PICU days, and hospital days. Currently recommended indications for RSV passive antibody prophylaxis were not predictive of prolonged ventilation, PICU stay, or hospital stay. A minority of infants admitted to our PICU for severe RSV disease meet currently recommended indications for RSV passive antibody prophylaxis. Risk factors that predict prolonged durations of ventilation, PICU stay, or hospital stay among this population include congenital heart disease, chronic lung disease, upper airway abnormalities, and noncardiac congenital malformations.Keywords
This publication has 20 references indexed in Scilit:
- Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996JAMA, 1999
- Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIVPediatrics, 1998
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin ProphylaxisPediatrics, 1997
- Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infectionThe Journal of Pediatrics, 1996
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993
- Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus InfectionClinical Pediatrics, 1993
- Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosisThe Journal of Pediatrics, 1988
- Respiratory Syncytial Viral Infection in Children with Compromised Immune FunctionNew England Journal of Medicine, 1986
- Respiratory Syncytial Viral Infection in Infants with Congenital Heart DiseaseNew England Journal of Medicine, 1982